Futura Medical plc. (FUM) Given “Corporate” Rating at N+1 Singer
Futura Medical plc. (LON:FUM)‘s stock had its “corporate” rating reaffirmed by equities research analysts at N+1 Singer in a report released on Thursday.
Shares of Futura Medical plc. (LON:FUM) opened at 64.85 on Thursday. The company’s 50-day moving average is GBX 56.33 and its 200 day moving average is GBX 29.32. Futura Medical plc. has a 1-year low of GBX 14.31 and a 1-year high of GBX 95.60. The stock’s market cap is GBX 64.26 million.
About Futura Medical plc.
Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin.
Receive News & Ratings for Futura Medical plc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical plc. and related companies with MarketBeat.com's FREE daily email newsletter.